Compare, Analyse ASTRAZENECA PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
TEVA PHARMA
Dec-13
ASTRAZENECA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2783,165-   
Low Rs8832,750-   
Sales per share (Unadj.) Rs228.41,816.5-  
Earnings per share (Unadj.) Rs10.4113.5-  
Cash flow per share (Unadj.) Rs16.3260.3-  
Dividends per share (Unadj.) Rs099.34-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs98.82,017.8-  
Shares outstanding (eoy) m25.00848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.71.6 290.5%   
Avg P/E ratio x104.226.1 400.0%  
P/CF ratio (eoy) x66.411.4 584.8%  
Price / Book Value ratio x10.91.5 746.3%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m27,0082,507,850 1.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m1,5350-   
Avg. sales/employee Rs Th4,210.934,273.2 12.3%   
Avg. wages/employee Rs Th1,132.20-   
Avg. net profit/employee Rs Th191.12,141.0 8.9%   
INCOME DATA
Net Sales Rs m5,7101,540,411 0.4%  
Other income Rs m1230-   
Total revenues Rs m5,8331,540,411 0.4%   
Gross profit Rs m463421,842 0.1%  
Depreciation Rs m147124,513 0.1%   
Interest Rs m030,256 0.0%   
Profit before tax Rs m438267,073 0.2%   
Minority Interest Rs m01,213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-175,319 0.0%   
Tax Rs m179-3,261 -5.5%   
Profit after tax Rs m25996,228 0.3%  
Gross profit margin %8.127.4 29.6%  
Effective tax rate %40.8-1.2 -3,345.5%   
Net profit margin %4.56.2 72.6%  
BALANCE SHEET DATA
Current assets Rs m3,2091,040,388 0.3%   
Current liabilities Rs m2,070907,306 0.2%   
Net working cap to sales %20.08.6 231.0%  
Current ratio x1.61.1 135.2%  
Inventory Days Days7291 79.7%  
Debtors Days Days3596 36.4%  
Net fixed assets Rs m790503,132 0.2%   
Share capital Rs m503,792 1.3%   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,4691,711,104 0.1%   
Long term debt Rs m0787,646 0.0%   
Total assets Rs m4,6053,520,332 0.1%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 283.3%   
Return on assets %5.63.6 156.6%  
Return on equity %10.55.6 186.6%  
Return on capital %17.74.9 359.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m88245,462 0.0%  
From Investments Rs m-94-86,977 0.1%  
From Financial Activity Rs mNA-294,448 0.0%  
Net Cashflow Rs m-6-135,963 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.83 Rs / USD

Compare ASTRAZENECA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ASTRAZENECA PHARMA With: ALEMBIC PHARMA  TTK HEALTHCARE  PFIZER  WYETH LTD  CIPLA  



Today's Market

Sensex Up Over 500 Points; IndusInd Bank, HDFC Bank & Hero MotoCorp Surge 5%(12:30 pm)

Share markets in India are presently trading on a strong note, in line with global peers that rallied as optimism over the reopening of economies buoyed investor sentiment.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio (Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

How Commodity Prices Tell You When Stocks Will Go Up (Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

Which Stocks Should You Buy, Sell, and Hold in the Market Today? (Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

Get Rich as the
Market Rebounds from Covid-19

Coronavirus Rebound
Get this special guide, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

ASTRAZENECA PHARMA SHARE PRICE


May 28, 2020 01:03 PM

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS